Non-steroidal anti-inflammatory topical eye drop solutions will be tested in a clinical trial to determine the efficacy of the drug in preventing the progression of non-central diabetic macular edema into center-involved diabetic macular edema. The study will be conducted by the Diabetic Retinopathy Clinical Research Network and sponsored by the National Institute of Health and National Eye Institute.